proline has been researched along with simvastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chanussot, F; Clerc, T; Diaconescu, N; Domingo, N; Hasselot, N; Jadot, G; Lafont, H; Laruelle, C; Moutardier, V; Rault, JP; Sbarra, V | 1 |
| Chen, S; Chew, TL; Danesh, FR; Jones, J; Kanwar, YS; Peng, H; Sadeghi, MM; Xu, H; Zeng, L | 1 |
| Abufreha, N; Dahari, H; Dizengof, V; Etzion, O; Nevo-Shor, A; Yardeni, D | 1 |
3 other study(ies) available for proline and simvastatin
| Article | Year |
|---|---|
Differences in hypolipidaemic effects of two statins on Hep G2 cells or human hepatocytes in primary culture.
Topics: Adult; Animals; Anticholesteremic Agents; Apolipoproteins; Bile Acids and Salts; Cell Line; Cell Survival; Cholesterol; Female; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins, HDL; Liver; Liver Neoplasms, Experimental; Lovastatin; Male; Proline; Simvastatin; Tumor Cells, Cultured | 1996 |
HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation.
Topics: Actin Cytoskeleton; Actins; Animals; Cells, Cultured; Collagen Type IV; Extracellular Matrix; Focal Adhesion Protein-Tyrosine Kinases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrin beta1; Mesangial Cells; Mevalonic Acid; Phosphorylation; Proline; Rats; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; Tritium; Tyrosine; Vascular Endothelial Growth Factor A | 2006 |
Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactams, Macrocyclic; Middle Aged; Proline; Ritonavir; Simvastatin; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2020 |